This new report provides analysis of Merck’s capabilities, goals and strategies in the global animal health market, including:
- Sales and growth
- Higher sales of Bravecto
- Vallée acquisition
- Extensive know-how in animal health
- Sphereon technology
- Expanding worldwide poultry business
- Poultry biological research laboratories
- Segmented poultry-product line
- Mitigated generic competition
- R&D productivity improving
- Patents, economies of scale, and powerful intellectual base
- Keytruda key to future
The report also provides assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and includes five-year forecasts for:
- Major market segments
- Key geographic regions
